Ep. 2020-11.1: BONUS Interview with Loren Lunsford, AuD, CCC-A, and Clay Gililland, HIS

Considering audiologists' experiences and learnings from the pandemic, what changes can be integrated into the business of hearing health care to improve practice owners' operations and financial acumen? Read the transcript here.

✦ Related stories ✦

Hearing Tracker·Industry news·Business & finance·8d ago

Amplifon Signs €1.35B Senior Loan to Help Finance GN Hearing Acquisition

If completed, the Amplifon–GN Hearing merger would create one of the most vertically integrated hearing healthcare companies in the world, potentially reshaping manufacturer–retailer relationships, pricing dynamics, and brand availability for independent clinics.

MedWatch·Financial report·Business & finance·2w ago

Barclays warns that hearing aid market's comeback could be short-lived

A potential softening of the premium hearing aid market could pressure clinic revenue, shift patient mix toward lower-cost devices, and affect manufacturer R&D investment across the field.

MedWatch·Industry news·Business & finance·7w ago

WS Audiology puts faith in own brands despite Italian-Danish megadeal

A potential Amplifon–GN deal would be one of the largest consolidations in hearing care history, and WSA's response strategy may affect product choices and brand availability for clinics and dispensers globally.

MedWatch·Industry news·Business & finance·8w ago

Italian owners evoke "mixed feelings" at GN

A change in ownership of a major hearing aid manufacturer could reshape product development priorities, brand identity, and supply relationships across the global audiology market.

MedWatch·Industry news·Business & finance·4w ago

Hearing aids were spared from Trump's tariffs—but the industry is keeping a close eye on finances

Tariff exemptions directly protect hearing-aid supply chains and affordability, but the episode underscores how exposed the sector is to geopolitical trade shifts.

MedWatch·Industry news·Business & finance·10d ago

Chief of finance resigns from WS Audiology

Leadership transitions at one of the world's largest hearing-aid groups can signal strategic shifts that eventually affect product pipelines, pricing, and clinic partnerships.

Audiology Worldnews·Industry news·Business & finance·5w ago

Demant completes divestment of Oticon Medical

Demant's complete exit from implantable hearing solutions reshapes the competitive landscape for bone-anchored and cochlear implant markets, potentially affecting clinician supplier choices and long-term product continuity.

Audiology Worldnews·Industry news·Business & finance·3d ago

Exclusive: Peter Justesen on Amplifon’s mega-deal and the future of GN Hearing

The potential Amplifon acquisition of GN Hearing would represent one of the largest consolidations in the hearing industry, with significant implications for product availability, pricing, and clinic supply chains.